TFAM公司
线粒体
线粒体DNA
DNAJA3公司
生物
转录因子
细胞生物学
抄写(语言学)
重编程
RNA聚合酶Ⅱ
癌细胞
癌症研究
线粒体融合
癌症
线粒体生物发生
基因表达
遗传学
细胞
基因
发起人
语言学
哲学
作者
Lei Tang,Yu Rui,Zhou Xiaoshuang,Jinglan Zhang,Zhang Jihong
标识
DOI:10.1038/s41420-024-01926-3
摘要
Mitochondria are major organelles involved in several processes related to energy supply, metabolism, and cell proliferation. The mitochondria function is transcriptionally regulated by mitochondria DNA (mtDNA), which encodes the key proteins in the electron transport chain that is indispensable for oxidative phosphorylation (OXPHOS). Mitochondrial transcriptional abnormalities are closely related to a variety of human diseases, such as cardiovascular diseases, and diabetes. The mitochondria transcription is regulated by the mtDNA, mitochondrial RNA polymerase (POLRMT), two transcription factors (TFAM and TF2BM), one transcription elongation (TEFM), and one known transcription termination factor (mTERFs). Dysregulation of these factors directly leads to altered expression of mtDNA in tumor cells, resulting in cellular metabolic reprogramming and mitochondrial dysfunction. This dysregulation plays a role in modulating tumor progression. Therefore, understanding the role of mitochondrial transcription in cancer can have implications for cancer diagnosis, prognosis, and treatment. Targeting mitochondrial transcription or related pathways may provide potential therapeutic strategies for cancer treatment. Additionally, assessing mitochondrial transcriptional profiles or biomarkers in cancer cells or patient samples may offer diagnostic or prognostic information.
科研通智能强力驱动
Strongly Powered by AbleSci AI